These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 26252502)
21. Immunostimulatory activity of dendritic cells pulsed with carbonic anhydrase IX and Acinetobacter baumannii outer membrane protein A for renal cell carcinoma. Kim BR; Yang EK; Kim SH; Moon DC; Kim HJ; Lee JC; Kim DY J Microbiol; 2011 Feb; 49(1):115-20. PubMed ID: 21369988 [TBL] [Abstract][Full Text] [Related]
22. Exosomes expressing carbonic anhydrase 9 promote angiogenesis. Horie K; Kawakami K; Fujita Y; Sugaya M; Kameyama K; Mizutani K; Deguchi T; Ito M Biochem Biophys Res Commun; 2017 Oct; 492(3):356-361. PubMed ID: 28851650 [TBL] [Abstract][Full Text] [Related]
23. Novel kidney cancer immunotherapy based on the granulocyte-macrophage colony-stimulating factor and carbonic anhydrase IX fusion gene. Hernández JM; Bui MH; Han KR; Mukouyama H; Freitas DG; Nguyen D; Caliliw R; Shintaku PI; Paik SH; Tso CL; Figlin RA; Belldegrun AS Clin Cancer Res; 2003 May; 9(5):1906-16. PubMed ID: 12738749 [TBL] [Abstract][Full Text] [Related]
24. Imaging of CAIX-expressing xenografts in vivo using 99mTc-HEHEHE-ZCAIX:1 affibody molecule. Honarvar H; Garousi J; Gunneriusson E; Höidén-Guthenberg I; Altai M; Widström C; Tolmachev V; Frejd FY Int J Oncol; 2015 Feb; 46(2):513-20. PubMed ID: 25434612 [TBL] [Abstract][Full Text] [Related]
25. Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion. Shin HJ; Rho SB; Jung DC; Han IO; Oh ES; Kim JY J Cell Sci; 2011 Apr; 124(Pt 7):1077-87. PubMed ID: 21363891 [TBL] [Abstract][Full Text] [Related]
26. CREB is a key negative regulator of carbonic anhydrase IX (CA9) in gastric cancer. Wang G; Cheng Z; Liu F; Zhang H; Li J; Li F Cell Signal; 2015 Jul; 27(7):1369-79. PubMed ID: 25843777 [TBL] [Abstract][Full Text] [Related]
27. The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths. Swietach P; Patiar S; Supuran CT; Harris AL; Vaughan-Jones RD J Biol Chem; 2009 Jul; 284(30):20299-310. PubMed ID: 19458084 [TBL] [Abstract][Full Text] [Related]
28. CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis. de Martino M; Klatte T; Seligson DB; LaRochelle J; Shuch B; Caliliw R; Li Z; Kabbinavar FF; Pantuck AJ; Belldegrun AS J Urol; 2009 Aug; 182(2):728-34. PubMed ID: 19539328 [TBL] [Abstract][Full Text] [Related]
29. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer. Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065 [TBL] [Abstract][Full Text] [Related]
30. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus. Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900 [TBL] [Abstract][Full Text] [Related]
31. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Tostain J; Li G; Gentil-Perret A; Gigante M Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527 [TBL] [Abstract][Full Text] [Related]
32. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182 [TBL] [Abstract][Full Text] [Related]
33. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma. Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038 [TBL] [Abstract][Full Text] [Related]
34. Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T-cell leukemia-derived cells. Nasu K; Yamaguchi K; Takanashi T; Tamai K; Sato I; Ine S; Sasaki O; Satoh K; Tanaka N; Tanaka Y; Fukushima T; Harigae H; Sugamura K Cancer Sci; 2017 Mar; 108(3):435-443. PubMed ID: 28075522 [TBL] [Abstract][Full Text] [Related]
36. Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma. Prayson RA; Chamberlain WA; Angelov L Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):422-8. PubMed ID: 20453815 [TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Olive PL; Aquino-Parsons C; MacPhail SH; Liao SY; Raleigh JA; Lerman MI; Stanbridge EJ Cancer Res; 2001 Dec; 61(24):8924-9. PubMed ID: 11751418 [TBL] [Abstract][Full Text] [Related]
38. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Chang DK; Moniz RJ; Xu Z; Sun J; Signoretti S; Zhu Q; Marasco WA Mol Cancer; 2015 Jun; 14():119. PubMed ID: 26062742 [TBL] [Abstract][Full Text] [Related]
39. DC-CTL targeting carbonic anhydrase IX gene combined with iAPA therapy in the treatment of renal cell carcinoma. Ma H; Tan Y; Wen D; Qu N; Kong Q; Li K; Ma S; Zhang J Hum Vaccin Immunother; 2021 Nov; 17(11):4363-4373. PubMed ID: 34851805 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy. Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]